To see the other types of publications on this topic, follow the link: Virus distribution.

Books on the topic 'Virus distribution'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 17 books for your research on the topic 'Virus distribution.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

LaVenture, George M. Software and the virus threat: Providing authenticity in distribution. Monterey, Calif: Naval Postgraduate School, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Spence, Nicola Jane. The identification, distribution and ecology of bean common mosaic virus in Africa. Birmingham: University of Birmingham, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kaupp, W. J. Ecology of European pine sawfly, Neodiprion sertifer (Geoff.) nuclear polyhedrosis virus: The distribution and accumulation of viral inclusion bodies in forest soils. [Sault Ste. Marie, Ont.]: Forest Pest Management Institute, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bānēt, Paphāsiri. Rāingān chabap sombūn rư̄ang kānphrǣkračhāi læ kānthāithō̜t chư̄a wairat rawāng kung khāo kap kung phư̄nmư̄ang nai lum Mǣnam Bāng Pakong =: Distribution and transmission of virus diseases between Litopenaeus vannamei and native shrimp species in Bangpakong watershed. [Bangkok]: Samnakngān Khana Kammakān Wičhai hǣng Chāt, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bānēt, Paphāsiri. Rāingān khrōngkān wičhai pī thī 2 rư̄ang kānphrǣ kračhāi læ kānthāithō̜t chư̄a wairat rawāng kung khāo kap kung phư̄nmư̄ang nai lum mǣnam Bāng Pakong =: Distribution and transmission of virus diseases between Litopenaeus vannamei and native shrimp species in Bangpakong watershed. [Bangkok?]: Samnakngān Khana Kammakān Wičhai hǣng Chāt, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

World Health Organization (WHO). Water Safety in Distribution Systems. World Health Organization, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Chang, L. W. H. Pests not known to occur in the United States or of limited distribution. 88. Plum pox virus. 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Chang, L. W. H. Pests not known to occur in the United States or of limited distribution. 89. Soybean dwarf virus. 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Books, Jonathon. Virus Transmission in Humans: Picture Quizzes Words Activity and Coloring Book 45 Image Blood Test, Distribution, Eyes, Fever, Dinner, Cough, Eye, Disease Prevention for Kids. Independently Published, 2020.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Vinod, Nikhra. COVID-19: Perspective, Patterns and Evolving strategies. Heighten Science Publications Inc., 2020. http://dx.doi.org/10.29328/ebook1003.

Full text
Abstract:
The Global Virome: The viruses have a global distribution, phylogenetic diversity, and host specificity. They are obligate intracellular parasites with single- or double-stranded DNA or RNA genomes, and afflict bacteria, plants, animals, and human population. The infecting virus binds to receptor proteins on the host cell surface, followed by internalisation, replication, and cell lysis. Further, trans-species interactions of viruses with bacteria, small eukaryotes and host are linked with various zoonotic viral diseases and disease progression.
APA, Harvard, Vancouver, ISO, and other styles
11

Kirchner, Jeffrey T. The Origin, Evolution, and Epidemiology of HIV-1 and HIV-2. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190493097.003.0002.

Full text
Abstract:
HIV-1 originated in the early 1920s in southern Cameroon and the Democratic Republic of Congo. From Africa, HIV rapidly spread in the late 1960s to the Caribbean and then the United States, Europe, and other areas of the world, leading to the global AIDS pandemic. Both HIV-1 and HIV-2 descended genetically from Simian immunodeficiency virus via cross-species transmission. HIV-1 group M was the first lineage discovered and represents the pandemic form of the virus. Group M consists of nine viral subtypes (A–K), has a widespread distribution, and accounts for approximately 95% of all HIV-1 infections. HIV-2 was not discovered until 1986 and makes up approximately 3% of cases worldwide. It is found mainly in West Africa. The genetic diversity of HIV does not appear to significantly affect viral response to antiretroviral therapy. However, viral diversity continues to present challenges for the development of an effective HIV vaccine.
APA, Harvard, Vancouver, ISO, and other styles
12

Chang, Ellen T., and Hans-Olov Adami. Nasopharyngeal Cancer. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780190676827.003.0008.

Full text
Abstract:
The distinctive global incidence patterns and risk factors for nasopharyngeal carcinoma (NPC) make this a unique malignancy that represents an epidemiologic challenge. NPC is rare throughout most of the world but relatively common in southern China, Southeast Asia, the Arctic, North Africa, and the Middle East. This pattern is determined in part by the geographic and ethnic distribution of established risk factors for NPC, which include early/aberrant Epstein Barr virus infection, Chinese-style salted fish consumption, family history, certain human leukocyte antigen alleles, and tobacco smoking. Other possible NPC risk factors include certain dietary, occupational, and infectious exposures and genetic variants. Risk factors for NPC in low-incidence regions, where tumors are more often of squamous cell histology than in high-incidence regions, are poorly understood, as are etiologic interactions among genetic, environmental, and infectious risk factors for NPC.
APA, Harvard, Vancouver, ISO, and other styles
13

Chang, Ellen T., and Allan Hildesheim. Nasopharyngeal Cancer. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0026.

Full text
Abstract:
The main epithelial malignancy arising in the nasopharynx is nasopharyngeal carcinoma (NPC). Although rare throughout most of the world, NPC has a unique geographic distribution, with high-risk endemic areas in southern China and parts of Southeast Asia, intermediate incidence rates elsewhere in Southeast Asia, North Africa, the Arctic, the Middle East, and among Asian and Pacific Islander migrants, and very low risk in other areas. The great majority of NPC cases worldwide are non-keratinizing tumors; these predominate in endemic, high-incidence areas and comprise up to half of tumors in low-incidence populations. The other histologic subtype of NPC, keratinizing squamous cell carcinoma, accounts for 40%–50% of cases in low-incidence areas. Infection with Epstein-Barr virus (EBV) is a necessary but not sufficient cause of non-keratinizing NPC, though it is more weakly associated with keratinizing squamous cell tumors. Tobacco smoking increases the risk of both subtypes.
APA, Harvard, Vancouver, ISO, and other styles
14

Sekhar, Rajagopal V. HIV-Associated Lipodystrophy and Lipoatrophy. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190493097.003.0046.

Full text
Abstract:
Patients with HIV have been seen to manifest unusual changes in body habitus that constitute variable combinations of peripheral fat loss ( lipoatrophy), central fat accumulation (lipohypertrophy), and the condition known as HIV-associated lipodystrophy (HAL). Although the origins of HAL are unclear, several factors have been linked to it. Because better antiretroviral therapy (ART) drug regimens have led to increased longevity, it is possible that the natural evolution of metabolic complications of HIV is the lipodystrophic phenotype. The specific effects of antiretroviral medications have also been implicated, and the initial usage of ART in the 1990s was accompanied by multiple reports of abnormalities in body fat distribution variously termed the “protease paunch,” “crixivan belly,” among others. Other factors include immune phenomenon and effects mediated directly by the HIV virus. Despite intensive research to understand the mechanistic underpinnings of HIV lipodystrophy and lipoatrophy, the answers remain elusive.
APA, Harvard, Vancouver, ISO, and other styles
15

Mukherjee, Joia S. Reversing the Tide. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190662455.003.0002.

Full text
Abstract:
This chapter focuses on the emergence of the AIDS pandemic. It covers the emergence of symptoms associated with HIV, the discovery of the virus, and the understanding of its transmission. It emphasizes the importance of AIDS activists in acceleration of the development of drugs that changed the disease from a terminal to chronic disease. AIDS activists throughout the world then worked together to fight for equitable distribution of AIDS treatment. The movement drew an explicit connection between the AIDS pandemic and the right to health and succeeded in garnering novel funding for global health delivery. AIDS changed many things in global health, from patient-led activism to drug discovery to the long-term provision of care. In this book, the global health era is defined as the period after 2000, when AIDS activism helped shift the health paradigm in impoverished countries from prevention only to the delivery of health care.
APA, Harvard, Vancouver, ISO, and other styles
16

World Health Organization (WHO). Report of the WHO Pandemic Influenza a (H1N1) Vaccine Deployment Initiative. World Health Organization, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

Medeiros, Mauricio, Beatriz Fialho, Priscila Soares, and Daniel Lacerda, eds. A primeira vacina 100% brasileira contra a Covid-19: a conquista de Bio-Manguinhos/Fiocruz. Fundação Oswaldo Cruz / Bio-Manguinhos, 2022. http://dx.doi.org/10.35259/vacinacovid.2022_52830.

Full text
Abstract:
The Covid-19 pandemic is a unique event in the modern history of humanity, which has generated great challenges and, at the same time, valuable opportunities for public health. A number of examples of them are found in the more than three hundred pages of this book. In each chapter it is possible to understand how a vaccine for Covid-19 was developed in record time - due to the urgency of an antidote that would allow us to deal with this terrible disease - through the acceleration, compliance and improvement of all labor criteria, production, evaluation, timely release, and security. This entire process of developing the first vaccine produced by Brazil was described in a very creative way, allowing the reader to dive into a technical-scientific content of the highest level. The book presents an overview that goes through the origin of the virus, the transmission mechanisms of SARS-CoV-2, the vaccine development process and the regulatory and legal instruments to guarantee access to vaccination - starting with the most vulnerable populations. It also describes the trials and phases of clinical study development that ensured the vaccine's safety and efficacy. It also covers the logistics of distribution and pharmacovigilance for monitoring the product in the user population until the detailing of the technological prospection, as well as showing the necessary steps to carry out a process of technology transfer of the vaccine from the viral vector. Among the various innovations, it is worth highlighting: preparation of a technological order through ETEC; use of continuous submission to the National Health Surveillance Agency (ANVISA); and emergency use authorization. This effort made it possible to meet the expressive demand for Covid-19 vaccines in Brazil in a timely manner and on an unprecedented scale. For the Pan American Health Organization (PAHO), which turns 120 on December 2, 2022, it is an honor to have Bio-Manguinhos/Fiocruz as part of our history. Due to its outstanding performance on the international scene, this institute is a true heritage of humanity. And now, with the first Brazilian vaccine for Covid-19, Bio-Manguinhos/Fiocruz consolidates Brazil's leadership in the production of immunobiologicals in Latin America and the Caribbean, ensuring greater self-sufficiency and sustainability of basic health supplies not only for the country, but for the entire region of the Americas.
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography